{"id":"W2765403114","doi":"10.1080/13696998.2018.1539400","title":"Cost-effectiveness analysis of secukinumab in ankylosing spondylitis from the Canadian perspective","year":2018,"lang":"en","type":"article","venue":"Journal of Medical Economics","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"ca_institutions":"Novartis (Canada); McMaster University","funders":"","keywords":"Medicine; Secukinumab; BASDAI; Golimumab; Adalimumab; BASFI; Ankylosing spondylitis; Certolizumab pegol; Etanercept; Infliximab; Population; Cost effectiveness; Discontinuation; Internal medicine; Tumor necrosis factor alpha; Disease","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009312998,0.00009901922,0.0006431846,0.0003114194,0.00008049013,0.00001590566,0.0001508196,0.0001194957,0.0009934738],"category_scores_gemma":[0.000618476,0.00006874021,0.0002330319,0.0003329075,0.0002721925,0.00005979756,0.0000317046,0.0002809472,0.000004036749],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001146399,"about_ca_system_score_gemma":0.0009247513,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.1853679,"about_ca_topic_score_gemma":0.6378275,"domain_scores_codex":[0.9988686,0.00009313745,0.0004644671,0.0001328694,0.000244659,0.0001962517],"domain_scores_gemma":[0.9986206,0.0004365734,0.0002385075,0.0001544516,0.0002563035,0.0002935509],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.002181344,0.0005178096,0.9336353,0.0000157065,0.01169644,0.001347499,0.009511017,0.00009051741,0.00001645398,0.005224929,0.0004586799,0.0353043],"study_design_scores_gemma":[0.005459615,0.0006049408,0.9789066,0.0003371979,0.001321714,0.0001443847,0.004121124,0.001212653,0.0001152302,0.001104048,0.006580306,0.00009220237],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9928798,0.001040243,0.00002901704,0.004368834,0.0003084087,0.0001555708,0.0001696851,0.000001503621,0.001046957],"genre_scores_gemma":[0.9984055,0.0005522834,0.0001036714,0.0005454319,0.0003636586,0.000002872346,0.00001400562,0.000008401904,0.000004142893],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4524596,"threshold_uncertainty_score":0.9999198,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03604495381201373,"score_gpt":0.3326350826472689,"score_spread":0.2965901288352552,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}